On the basis of the data that IDH-mutant gliomas have both increased global DNA methylation and survival compared with IDH wild-type gliomas, and that there is in vivo and in vitro data showing folate treatment can reduce growth of glioma cells, we tested whether the DNA methylome of IDH wild-type gliomas could be reprogrammed. The gene discussed is IDH1; the disease is glioma.